Journal of Jilin University(Medicine Edition) ›› 2020, Vol. 46 ›› Issue (03): 662-667.doi: 10.13481/j.1671-587x.20200338
• Review • Previous Articles
Research progress in circulating tumor cells as a new generation of tumor marker
-
Received:2019-07-15Published:2020-06-11
CLC Number:
- R73
Cite this article
share this article
| [1] 李健斌, 江泽飞. 循环肿瘤细胞研究进展:从计数到表型的转变[J].中华肿瘤杂志, 2016, 38(12):881-885. [2] CHAFFER C L, SAN JUAN B P, LIM E, et al. EMT, cell plasticity and metastasis[J]. Cancer Metastasis Rev, 2016, 35(4):645-654. [3] MARRINUCCI D, BETHEL K, BRUCE R H, et al. Case study of the morphologic variation of circulating tumor cells[J]. Hum Pathol, 2007, 38(3):514-519. [4] CHEUNG K J, EWALD A J. A collective route to metastasis:Seeding by tumor cell clusters[J]. Science, 2016, 352(6282):167-169. [5] SKUBITZ A P, TARAS E P, BOYLAN K L, et al. Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression[J]. Gynecol Oncol, 2013, 130(3):579-587. [6] MAO S F, ZHANG Q, LI H F, et al. Adhesion analysis of single circulating tumor cells on a base layer of endothelial cells using open microfluidics[J]. Chem Sci, 2018, 9(39):7694-7699. [7] KROG B L, HENRY M D. Biomechanics of the circulating tumor cell microenvironment[J]. Adv Exp Med Biol, 2018, 1092:209-233. [8] LIBERKO M, KOLOSTOVA K, BOBEK V. Essentials of circulating tumor cells for clinical research and practice[J]. Crit Rev Oncol Hematol, 2013, 88(2):338-356. [9] SOLER A, CAYREFOURCQ L, MAZARD T, et al. Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes[J]. Sci Rep, 2018, 8(1):15931. [10] FABISIEWICZ A, GRZYBOWSKA E. CTC clusters in cancer progression and metastasis[J]. Med Oncol, 2017, 34(1):12. [11] VAN ES N, STURK A, MIDDELDORP S, et al. Effects of cancer on platelets[J]. Semin Oncol, 2014, 41(3):311-318. [12] AMIRKHOSRAVI A, MOUSA S A, AMAYA M, et al. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpⅡb/Ⅲa antagonist XV454[J]. Thromb Haemost, 2003, 90(3):549-554. [13] FELDING-HABERMANN B, HABERMANN R, SALDIVAR E, et al. Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow[J]. J Biol Chem, 1996, 271(10):5892-5900. [14] YIE S M, LUO B, YE N Y, et al. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA[J]. Clin Exp Metastasis, 2006, 23(5/6):279-289. [15] VEGRAN F, BOIDOT R. Survivin-3B promotes chemoresistance and immune escape by inhibiting caspase-8 and -6 in cancer cells[J]. Oncoimmunology, 2013, 2(11):e26328. [16] SAKAGUCHI S, YAMAGUCHI T, NOMURA T, et al. Regulatory T cells and immune tolerance[J]. Cell, 2008, 133(5):775-787. [17] CHOI J, SUH B, AHN Y O, et al. CD15+/CD16 low human granulocytes from terminal cancer patients:granulocytic myeloid-derived suppressor cells that have suppressive function[J]. Tumour Biol, 2012, 33(1):121-129. [18] XU J M, ZHANG Y, JIA R, et al. Anti-PD-1 antibody SHR-1210 combined with apatinib for advanced hepatocellular carcinoma, gastric, or esophagogastric junction cancer:an open-label, dose escalation and expansion study[J]. Clin Cancer Res, 2019, 25(2):515-523. [19] GASCOYNE P R, NOSHARI J, ANDERSON T J, et al. Isolation of rare cells from cell mixtures by dielectrophoresis[J]. Electrophoresis, 2009, 30(8):1388-1398. [20] LIU Z X, GUO W X, ZHANG D D, et al. Circulating tumor cell detection in hepatocellular carcinoma based on karyoplasmic ratios using imaging flow cytometry[J]. Sci Rep, 2016, 6:39808. [21] HAROUAKA R A, ZHOU M D, YEH Y T, et al. Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells[J]. Clin Chem, 2014, 60(2):323-333. [22] SARIOGLU A F, ACETO N, KOJIC N, et al. A microfluidic device for label-free, physical capture of circulating tumor cell clusters[J]. Nat Methods, 2015, 12(7):685-691. [23] CHEN L J, PENG M, LI N, et al. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer[J]. Sci Rep, 2018, 8(1):1188. [24] ZHANG Y J, WANG F, NING N, et al. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer[J]. Int J Cancer, 2015, 136(5):1228-1233. [25] GOODALE D, PHAY C, POSTENKA C O, et al. Characterization of tumor cell dissemination patterns in preclinical models of cancer metastasis using flow cytometry and laser scanning cytometry[J]. Cytometry A, 2009, 75(4):344-355. [26] ANDREE K C, VAN DALUM G, TERSTAPPEN L W. Challenges in circulating tumor cell detection by the cell search system[J]. Mol Oncol, 2016, 10(3):395-407. [27] SEQUIST L V, NAGRATH S, TONER M, et al. The CTC-chip:an exciting new tool to detect circulating tumor cells in lung cancer patients[J]. J Thorac Oncol, 2009, 4(3):281-283. [28] STUTTERHEIM J, ICHOU F A, DEN OUDEN E, et al. Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma[J]. Clin Cancer Res, 2012, 18(3):808-814. [29] EBERWINE J, SUL J Y, BARTFAI T, et al. The promise of single-cell sequencing[J]. Nat Methods, 2014, 11(1):25-27. [30] RAGHUNATHAN A, FERGUSON H R, BORNARTH C J, et al. Genomic DNA amplification from a single bacterium[J]. Appl Environ Microbiol, 2005, 71(6):3342-3347. [31] ZONG C H, LU S J, CHAPMAN A R, et al. Genome-wide detection of single-nucleotide and copy-number variations of a single human cell[J]. Science, 2012, 338(6114):1622-1626. [32] JIANG R Z, LU Y T, HO H, et al. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer[J]. Oncotarget, 2015, 6(42):44781-44793. [33] GAO Y Y, ZHU YY, ZHANG Z Z, et al. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization[J]. J Exp Clin Cancer Res, 2016, 35:66. [34] ILIE M, HOFMAN V, LONG-MIRA E, et al. "Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease[J]. PLoS One, 2014, 9(10):e111597. [35] CHEN X X, ZHOU F, LI X F, et al. Folate receptor-positive circulating tumor cell detected by lt-pcr-based method as a diagnostic biomarker for non-small-cell lung cancer[J]. J Thorac Oncol, 2015, 10(8):1163-1171. [36] NAITO T, TANAKA F, ONO A, et al. Prognostic impact of circulating tumor cells in patients with small cell lung cancer[J]. J Thorac Oncol, 2012, 7(3):512-519. [37] ANKENY J S, COURT C M, HOU S, et al. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer[J]. Br J Cancer, 2016, 114(12):1367-1375. [38] QIAO G L, QI W X, JIANG W H, et al. Prognostic significance of circulating tumor cells in esophageal carcinoma:a meta-analysis[J]. Oncol Targets Ther, 2016, 9:1889-1897. [39] HELLER G, MCCORMACK R, KHEOH T, et al. Circulating tumor cell number as a response measure of prolonged survival for metastatic castration-resistant prostate cancer:a comparison with prostate-specific antigen across five randomized phase Ⅲ clinical trials[J]. J Clin Oncol, 2018, 36(6):572-580. [40] SHIMAZU K, FUKUDA K, YOSHIDA T, et al. High circulating tumor cell concentrations in a specific subtype of gastric cancer with diffuse bone metastasis at diagnosis[J]. World J Gastroenterol, 2016, 22(26):6083-6088. [41] GEMENETZIS G, GROOT V P, YU J, et al. Circulating tumor cells dynamics in pancreatic adenocarcinoma correlate with disease status:results of the prospective CLUSTER study[J]. Ann Surg, 2018, 268(3):408-420. [42] SHEN J Q, ZHAO J, JIANG T, et al. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy[J]. Oncotarget, 2017, 8(30):49044-49052. [43] CHEN J F, HO H, LICHTERMAN J, et al. Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases[J]. Cancer, 2015, 121(18):3240-3251. [44] DE BONO J S, SCHER H I, MONTGOMERY R B, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer[J]. Clin Cancer Res, 2008, 14(19):6302-6309. [45] SPARANO J, O'NEILL A, ALPAUGH K, et al. Association of circulating tumor cells with late recurrence of estrogen receptor-positive breast cancer:a secondary analysis of a randomized clinical trial[J]. JAMA Oncol, 2018, 4(12):1700-1706. [46] PAPADAKI M A, STOUPIS G, THEODOROPOULOS P A, et al. Circulating tumor cells with stemness and epithelial-to-mesenchymal transition features are chemoresistant and predictive of poor outcome in metastatic breast cancer[J]. Mol Cancer Ther, 2019, 18(2):437-447. [47] SHEN J, WANG W S, ZHU X L, et al. High epithelial cell adhesion molecule-positive circulating tumor cell count predicts poor survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization[J]. J Vasc Interv Radiol, 2018, 29(12):1678-1684. [48] PANTEL K, ALIX-PANABIERES C. Functional studies on viable circulating tumor cells[J]. Clin Chem, 2016, 62(2):328-334. [49] PESTRIN M, BESSI S, PUGLISI F, et al. Final results of a multicenter phase Ⅱ clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study[J]. Breast Cancer Res Treat, 2012, 134(1):283-289. [50] PACHMANN K, SCHUSTER S. The value of monitoring the behavior of circulating tumor cells at the end of endocrine therapy in breast cancer patients[J]. Cancers (Basel), 2018, 10(11):E407. [51] GOODMAN C R, SEAGLE B L, FRIEDL T W P, et al. Association of circulating tumor cell status with benefit of radiotherapy and survival in early-stage breast cancer[J]. JAMA Oncol, 2018, 4(8):e180163. [52] SCHER H I, GRAF R P, SCHREIBER N A, et al. Assessment of the validity of nuclear-localized androgen receptor splice variant 7 in circulating tumor cells as a predictive biomarker for castration-resistant prostate cancer[J]. JAMA Oncol, 2018, 4(9):1179-1186. |
| [1] | . Research progress in clinical application of Raman spectroscopyin breast cancer [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 413-418. |
| [2] | WU Xueyan, ZHAO Yina, WANG Xiaojie, MA Wenyi, WANG Xinjie, LI xin. Effect of galectin-3 expression suppression on expressions of Bcl-2 and Bax in gastric cancer MGC-803 cells and its promotion on apoptosis [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 335-339. |
| [3] | ZHANG Chu, HAO Miao, WANG Huiyu, WANG Xiaofeng, ZHANG Tianfu. Effect of Oxaliplatin on proliferation and apoptosis of human tongue squamous cell carcinoma CAL27 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 233-239. |
| [4] | ZHANG Lifang, CAI Lin, WANG Yunhua, ZHANG Keshi, WU Rina. Analysis on association between selenoprotein P polymorphism and risk of papillary thyriod carcinoma [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 383-388. |
| [5] | SONG Hongyun, PAN Ying, AN Furun, ZHANG Jiakui, YANG Dongdong, ZHAI Zhimin. Clinical characteristics of acute leukemia patients with complex karyotypes and their effects on prognosis [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 377-382. |
| [6] | LIU Hui, MA Yunfei, LIU Bailong, LIU Min. Anlotinib combined with thoracic radiotherapy in treatment of recurrent and refractory small cell lung cancer: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 394-398. |
| [7] | WANG Huiyu, ZHANG Tianfu, HAO Miao, ZHANG Chu, WANG Xiaofeng. Inhibitory effect of polysaccharides from panax ginseng fruit on proliferation of human lingual squamous cell carcinoma CAL27 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 248-253. |
| [8] | XU Jianguo, CAO Hongtao, ZHANG Zilong, JI Baoyan, WANG Chunqiu, LI Shengdong, LIU Guoqing. Effects of LincRNA-p21 knockdown on growth and metastasis of gastric cancer cells and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 266-273. |
| [9] | NIE Man, YUE Jun. Effects of TP53 G199X and V157fs on function of ovarian cancer A2780 cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 292-296. |
| [10] | HE Yingying, XUE Jinhui, ZHAO Na. Effects of rhein on proliferation, migration and invasion abilities of non-small cell lung cancer A549 cells and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 302-308. |
| [11] | CHEN Zhouhua, GONG Hui, FENG Lei, XIAO Yujie, HUANG Lizhong. Induction of LPS on epithelial mesenchymal transition in breast cancer MDA-MB-231 cells and its effect on β-catenin expression [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 309-315. |
| [12] | MENG Shuang, LI Yingjie, ZANG Xiaozhen, ZHAO Qianfang, ZHANG Jin, LI Jing. Inhibitory effect of knockdown of TLR2 gene on proliferation of colorectal cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 316-322. |
| [13] | XIAO Hua, YAO Shengtao. Effects of TRIM29-siRNA transfection on cell cycle and apoptosis of glioma U87MG cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 323-328. |
| [14] | LI Ruiyang, LIN Zhiyi, LI Jing, FEI Jing, XU Dan, GONG Ping. Changes of IGF-1 and mTOR expressions in peripheral blood of patients with non-small cell lung cancer before and after chemotherapy combined with metformin and analysis on their therapeutic effects [J]. Journal of Jilin University(Medicine Edition), 2020, 46(01): 108-115. |
| [15] | FENG Jie, REN Liqun, CHEN Suxian, WAN Yizeng, XU Peibin. Inhibitory effects of cucurbitacin B combined with oxaliplatin on proliferation and apoptosis of human colon cancer SW480 cells and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2020, 46(01): 78-83. |
|
||